ABOUT THE CASE COMPREHENSIVE CANCER CENTER
The Case Comprehensive Cancer Center (Case CCC) based at Case Western Reserve University (CWRU) is a partnership organization supporting all cancer related research efforts at CWRU, University Hospitals Case Medical Center, and the Cleveland Clinic. Located in Cleveland, Ohio, the Case CCC serves the cancer research and clinical needs of an urban manufacturing and rural agricultural region containing 3.8 million people in Northern Ohio
University Hospitals Seidman Cancer Center, part of the Case Comprehensive Cancer Center, is dedicated to innovative treatment and promising research in the fight against cancer through ongoing studies aimed at cancer treatment and prevention.
One of only 41 Comprehensive Cancer Centers in the country designated by the National Cancer Institute (NCI), Seidman can offer cutting-edge treatments earlier than most other cancer centers. Our affiliation with Case Western Reserve University provides ongoing studies aimed at cancer treatment and prevention.
Patients receive skilled care through our multidisciplinary team approach . Experts in surgery, medical oncology, radiation therapy, pathology, nursing, social work and psychology work together to create a personalized treatment plan that meets physical, emotional and spiritual needs.
Recognized by U.S. News and World Report as one of the top hospitals for cancer care in the country, the mission of Seidman Cancer Center is simple: to cure cancer
Taussig Cancer Institute provides world-class care to patients with cancer and is at the forefront of new and emerging clinical, translational and basic cancer research.
Cleveland Clinic is moving toward the forefront of the cancer drug discovery revolution and cancer research. Through cancer research, we have identified new molecules with anti-tumor effects, developed collaborative ties with biotechnology companies, begun training more young scientists, and expanded our base of financial support. These bold steps in cancer research will result in discovery and application of new therapies to help us eliminate cancer as a significant cause of mortality.
Viracor-IBT Laboratories is accelerating medicine through innovative molecular and immunodiagnostics, scientific expertise and exceptional services. We deliver solutions to challenging clinical diagnostic problems in infectious disease, allergy, hypersensitivity and immune disorders. Leveraging our expertise and clinical reference laboratory experience, Viracor-IBT Laboratories works with vaccine, pharmaceutical, biotech and medical device developers to provide infectious disease testing, immune monitoring and bioanalytical services.